Top Tweets for #CEMarkOnly
Hear from Dr. Dierk Scheinert about the first ever prospective randomized 414 pt head-to-head trial studying the latest generation Ranger DCB against InPact DCB. “same results with ~half the drug” #EHJournal #LevelOneEvidence #PAD #CEMarkOnly
COMPARE RCT shows similar key outcomes between low-and high-dose drug-coated balloons (Dierk Scheinert) - https://t.co/s3QwBHOd9V @TimYatesMD @UniLeipzig @krosenfieldMD @hmpVDM @PK_MountSinai @nick_inston @Thuaimer @JimGMelton @SandipNandhra @Kniery_Bird #AlwaysBLearning
Congrats & TY to Dr. Steiner and all the investigators. COMPARE, the first head-to-head DCB trial re-affirms #RangerDCB high efficacy in complex lesions (12 cm, 41% CTO, 50% mod/sev calcium). #CEMarkOnly #PAD
Join us in the #LINC2020 video studio for a discussion of the COMPARE trial 12-month data, presented for the first time by Sabine Steiner, MD. https://t.co/OSEGMxr613
Congrats to Prof. Dierk Scheinert & Dr. Sabine Steiner for the first H2H 1:1 RCT trial & simultaneous publication in EHJ #EvidenceBasedMedicine #RangerDCB #CEMarkOnly @escardio
Late Breaking @ #LINC2020 COMPARE trial: Worlds 1st head to head DCB trial comparing low dose #RangerDCB vs high dose IN.PACT. 1 yr results show similar patency for Ranger w/ half the drug. K-M primary patency of 88.4% Ranger vs 89.4% IN.PACT. #CEMarkOnly
Ranger II results are in at #LINC2020: full 12mo cohort data shows an 89.8% K-M primary patency w/ Ranger vs 74% w/ PTA. Significantly lower TLR Rate for #RangerDCB at 5.5% vs 16.5% for PTA. #CEMarkOnly Excited to continue my career advancing #EvidenceBasedMedicine w/ @bsc_pi.
Late Breaking @ #LINC2020 COMPARE trial: Worlds 1st head to head DCB trial comparing low dose #RangerDCB vs high dose IN.PACT. 1 yr results show similar patency for Ranger w/ half the drug. K-M primary patency of 88.4% Ranger vs 89.4% IN.PACT. #CEMarkOnly
TY Dr. Andrej Schmidt for a great live case out of Leipzig at #ISET2020 today using 6x80 #EluviaDES proximal and #RangerDCB distal to treat a complex lesion #PAD [Ranger #CEMarkOnly]
Proud to support the first & only randomized, sham controlled trial in #PAE. Thinking of Dr. Pisco et al whose legacy will live on with this landmark publication. Committed to advancing science in #Irad. #MIIP #LevelOneEvidence #BPH #CEMarkOnly
https://t.co/LpUFPuK66A
#LateBreaker @ #VIVA19: #RangerDCB 12mo results show a Kaplan Meier primary patency of 89.2% compared to 72.9% in pts treated w/ standard PTA & Ranger DCB had a significantly lower TLR rate of 6%, in contrast to 17.9% PTA. #CEMarkOnly @VIVAPhysicians
#VIRTUS trial quality of life results presented @ #AVF19 by Dr. William Marston: At 12 months, ~65% of patients saw rVCSS improvement of 3 or more #VenousDisease #ViciStent #CEMarkOnly
@mms62786 75% pts were Chronic Post Thrombotic, 66% Severe VCSS >8, 25% CEAP Class C5 & C6, 31% Total Occlusions and 32% involving the entire iliofemoral segment. Happy to send the podium slides if u wish. More info here: https://t.co/rwDZuV5Vwt #DVT #VenousDisease #VICIStent #CEMarkonly
Busy morning at #LINC2019: Dr. Scheinert presents world’s 1st H2H #DCB trial COMPARE: 2 yr results show new gen Ranger DCB demonstrated similar patency & freedom from TLR w/ low dose compared to higher dose IN.PACT DCB #PAD #H2HTrial #Level1Evidence #CEMarkOnly
Happening Now @ #LINC2019: VIRTUS clinical trial results of VICI Stent primary endpoint achieved 84% primary patency at 12 months in severely diseased patients w/ challenging lesions #PTS #VICIStent #VenousDisease #CEMarkOnly
Today @ #LINC: Dr. Bill Gray & Prof. Dierk Scheinert sharing two H2H drug-eluting clinical trial designs (IMPERIAL & COMPARE-1) plus a difficult live case by Prof. Andrej Schmidt who took a retrograde approach w/ Eluvia in the mid SFA & Ranger in the P1 segment #PAD #CEMarkOnly
Exciting news in UK today: 1st worldwide Ranger DCB Long Length implant by Dr. James Kirk! 71 y/o F who had previous angioplasty #CEMarkOnly
Last Seen Hashtags on Sotwe
lesbian facesitting licking ass
Seen from Turkey
Snapgod
Seen from United States
blackpyt
Seen from United States
เย็ดสาวพึ่งคลอด
Seen from Thailand
2020年のたけし
Seen from United States
女初
Seen from United States
Momson
Seen from Australia
无手射
Seen from Singapore
Gamechanger
Seen from United States
นัดเย็ดสัตหีบ
Seen from Thailand
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.3M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers